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300482Abstract—Our study compared three elastographic methods—transient elastography (TE), acoustic radiation
force impulse (ARFI) imaging and supersonic shear imaging (SSI)—with respect to the feasibility of their use in
liver fibrosis evaluation. We also compared the performance of ARFI imaging and SSI, with TE as the reference
method. The study included 332 patients, with or without hepatopathies, in which liver stiffness was evaluated
using TE, ARFI and SSI. Reliable measurements were defined as a median value of 10 (TE, ARFI imaging) or
5 (SSI) liver stiffness measurements with a success rate$60% and an interquartile range interval,30%. A signif-
icantly higher percentage of reliable measurements were obtained using ARFI than by using TE and SSI: 92.1%
versus 72.2% (p , 0.0001) and 92.1% versus 71.3% (p , 0.0001). Higher body mass index and older age were
significantly associated with inability to obtain reliable measurements of liver stiffness using TE and SSI. In
55.4% of patients, reliable liver stiffness measurements were obtained using all three elastographic methods,
and ARFI imaging and TE were similarly accurate in diagnosing significant fibrosis and cirrhosis, with TE as
the reference method. (E-mail: isporea@umft.ro)  2013 World Federation for Ultrasound in Medicine &
Biology.
Key Words: Liver stiffness, Liver fibrosis, Transient elastography, Acoustic radiation force impulse elastography,
Supersonic shear imaging.INTRODUCTION
Chronic liver diseases are quite common in daily practice.
In some areas, chronic viral hepatitis B and/or hepatitis C
are dominant, and in others, non-viral chronic hepatopa-
thies (alcoholic or non-alcoholic steatohepatitis) are more
common. To assess the severity of chronic liver diseases,
the hepatologist can use invasive (liver biopsy) or non-
invasive techniques.
After its introduction into daily practice, the first
liver biopsy being performed in 1923 (Bingel 1923),
percutaneous liver biopsy became an indispensable tool
for the evaluation of liver diseases. Because liver biopsy
offers information regarding fibrosis stage, necro-
inflammation and fatty infiltration and reveals specific
markers in certain hepatic diseases, this morphologic
examination is considered the ‘‘gold standard’’ method
for assessment of liver diseases (Grant and Neuberger
1999; Rockey et al. 2009). However, we must considerddress correspondence to: Ioan Sporea, 13, Snagov Street,
Timisoara, Romania. E-mail: isporea@umft.ro
1933that after diagnostic liver biopsy, minor or serious
complications, including death, may occur in 1–5% of
cases (Piccinino et al. 1986), and that liver biopsy has
limitations because of the uneven distribution of liver
fibrosis (Bedossa et al. 2003), the small size of the spec-
imen (approximately 1/50,000th of the total volume of
the liver) (Afdhal 2006) and inter- and intra-observer
diagnostic discrepancies in biopsy assessments of liver
fibrosis (Bedossa et al. 1994). For these reasons, several
non-invasive methods for liver fibrosis assessment have
been developed in the last 10–15 y.
Serologic tests were the first ones to be developed;
they can be used evaluate liver fibrosis (Guha et al.
2008) and activity and fibrosis (Poynard et al. 2004).
Subsequently, transient elastography (TE), commercial-
ized as the FibroScan, a shear wave ultrasound elasto-
graphic method, began to be used for liver fibrosis
assessment. Several published studies and meta-
analyses (Friedrich-Rust et al. 2008; Sandrin et al.
2003; Tsochatzis et al. 2011) have reported that TE is
a reliable diagnostic tool for the non-invasive evaluation
of liver fibrosis, especially in patients with chronic
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but also in those with chronic hepatitis B (Chon et al.
2012; Marcellin et al. 2009) and non-alcoholic steatohe-
patitis (Wong et al. 2010) and in post-transplant patients
(Adebajo et al. 2012). TE also has some limitations: it is
hampered by the presence of ascites because TE waves
cannot penetrate into ascites; obesity significantly
decreases the rate of reliable measurements (Castera
et al. 2010); aminotransferases flares are associated
with falsely elevated TE values (Coco et al. 2007,
Vigano et al. 2010); and extra-hepatic cholestasis
(Millonig et al. 2008) and high central venous pressure
(Millonig et al. 2010) falsely increase the liver stiffness
values assessed by TE. Also, the FibroScan device is
quite expensive and, thus, in some countries, the number
of available systems is limited.
In the last 3 y, several real-time elastographic
methods have been used for the non-invasive assessment
of liver fibrosis. They can be classified into two cate-
gories: train methods, such as real-time tissue elastogra-
phy (Havre et al. 2008), and shear wave methods, such
as acoustic radiation force impulse (ARFI) elastography
(Friedrich-Rust et al. 2007) and supersonic shear imaging
(SSI) (Bavu et al. 2011). Unlike TE, real-time elasto-
graphic methods are included in standard ultrasound
systems that can be used for many other purposes (stan-
dard ultrasound examination, Doppler evaluation,
contrast-enhanced ultrasound), so that these devices are
more cost effective. Another advantage is that patients
with ascites can also be evaluated by means of real-
time techniques.
Among the real-time elastographic methods, ARFI
has been studied the most. A recently published meta-
analysis (Friedrich-Rust et al. 2012) indicated that it is
a good method for liver fibrosis evaluation, with accura-
cies of 0.87 in predicting significant fibrosis (F $ 2),
0.91 in predicting severe fibrosis (F$ 3) and 0.93 in pre-
dicting liver cirrhosis. SSI is the latest to appear on the
market, and there are few, although promising, published
studies regarding this technique (Bavu et al. 2011,
Ferraioli et al. 2012).
The main aim of this study was to compare the feasi-
bility of using the three elastographic methods involving
ultrasound shear waves (TE, ARFI and SSI). The
secondary aim was to compare ARFI elastography and
SSI with respect to performance in the assessment of liver
fibrosis assessment, with TE as the reference method,
because TE has already been validated for the evaluation
of liver fibrosis (Adebajo et al. 2012; Castera et al. 2005;
Chon et al. 2012; European Association for the Study of
the Liver 2011, 2012; Marcellin et al. 2009; Tsochatzis
et al. 2011; Wong et al. 2010).METHODS
Patients
Our study included 332 consecutive patients for
whom liver stiffness (LS) was evaluated in the same
session using three elastographic methods: TE, ARFI
and SSI. The subjects were: healthy volunteers (medical
students, nurses and medical doctors from our hospital:
none had a history of liver disease, but additional tests,
such as biological tests and viral markers, were not per-
formed, with the exception of an ultrasound examination,
which was normal); patients with chronic hepatitis B and
C; patients with chronic non-viral hepatitis (such as alco-
holic or non-alcoholic steatohepatitis, autoimmune hepa-
titis, primary biliary cirrhosis); and patients previously
diagnosed with liver cirrhosis on the basis of clinical, bio-
logic, ultrasonographic, morphologic and/or laparoscopic
criteria.
All patients included in our study had a homoge-
neous liver structure (without focal liver lesions) and no
ascites on abdominal ultrasound examination.
All patients signed an informed consent before elas-
tographic measurements; the study was approved by the
local ethics committee and was performed in accordance
with the Helsinki Declaration of 1975.Transient elastography
Liver stiffness was measured by means of TE using
the FibroScan device (EchoSens, Paris, France), which
incorporates a 5-MHz ultrasound transducer probe
mounted on the axis of a vibrator. The vibrator generates
a completely painless vibration (50-Hz frequency and
2-mm amplitude), which induces an elastic shear wave
propagating through the skin and the subcutaneous tissue
to the liver, which is tracked using the coaxial ultrasound
transducer. The wave velocity is directly related to tissue
stiffness, which is calculated by the device and expressed
in kilopascals (Sandrin et al. 2003).
For each patient, 10 valid TE measurements were
performed under fasting conditions. The patient was in
the supine position, by the intercostal approach, with
the right arm in maximum abduction. A standard
M-probe was used. The median value was calculated
and expressed in kilopascals. A reliable measurement
was defined as the median of 10 valid LS measurements
with a success rate (SR 5 ratio of number of successful
acquisitions to total number of acquisitions) $60% and
an interquartile range (IQR 5 difference between 75th
and 25th percentiles, essentially the range of the middle
50% of the data) ,30% (Fig. 1). The median of 10 valid
measurements was considered as indicative of the
severity of fibrosis.
Fig. 1. Transient elastography measurement. On the screen are
displayed the liver stiffness expressed in kilopascals (kPa), the
interquartile range (IQR) and the success rate.
Fig. 2. Acoustic radiation force impulse measurement. The
measurement is performed in the area enclosed by the box.
On the screen are displayed the velocity (in m/s) and depth of
the measurement.
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failed if no valid measurement was obtained after at least
10 attempts; a measurement was considered unreliable if
fewer than 10 valid attempts were made; SR, 60% and/
or IQR $ 30% (Castera et al. 2010). In TE, the system
automatically displays on the screen the median, IQR
and SR.
Transient elastography measurements were per-
formed by four experienced operators who had performed
more than 1000 examinations each (one operator per
patient) and who were blinded to all clinical and other
elastographic data.
Because TE is a validated method for liver fibrosis
evaluation (Adebajo et al. 2012; Castera et al. 2005;
Chon et al. 2012; European Association for the Study
of the Liver 2011, 2012; Marcellin et al. 2009;
Tsochatzis et al. 2011; Wong et al. 2010), it was
considered the reference method against which the
performance of ARFI and SSI elastography was
assessed. To discriminate between the various stages of
fibrosis with TE, we used the latest published LS
cutoffs proposed in the Tsochatzis meta-analysis
(Tsochatzis et al. 2011): 7.2 kPa for significant fibrosis
(F $ 2) and 14.5 kPa for liver cirrhosis (F 5 4)
(Tsochatzis et al. 2011).
Acoustic radiation force impulse elastography
Acoustic radiation force impulse elastography was
performed with a Siemens Acuson S2000 Virtual Touch
ultrasound system (Siemens AG, Erlangen, Germany)
with a 4CI transducer. The principle underlying ARFI
elastography is that shearing of the examined tissue
induces a strain in the tissues. An acoustic ‘‘push’’ pulse
is automatically produced by the ultrasound probe and
directed to the side of a region of interest (ROI), whichis where the speed of the shear wave is measured. This
ROI has a predefined size, provided by the system
(10 mm long and 5 mmwide). The acoustic ‘‘push’’ pulse
generates shear waves that propagate into the tissue,
perpendicular to the ‘‘push’’ axis. Detection waves are
also generated by the transducer to measure the propaga-
tion speed of these shear waves, which increases with
fibrosis severity (Palmeri et al. 2008). The speed of the
shear waves, measured in meters per second, as well as
measurement depth, is displayed by the system.
For each patient, 10 valid ARFI measurements were
performed under fasting conditions, with the patient in
supine position with the right arm in maximum abduc-
tion, by the intercostal approach in the right liver lobe,
1–2 cm under the liver capsule. Minimal scanning pres-
sure was applied by the operator; the patient was asked
to stop normal breathing for a moment to minimize
breathing motion (Fig. 2). The median of 10 valid
measurements was calculated and considered indicative
of the severity of fibrosis.
Acoustic radiation force impulse measurements
were performed by one of three operators, each of
whom had at least 2 y of experience in conventional
ultrasound examination and had performed more than
150 ARFI measurements. The operators were blinded to
any clinical or elastographic data.
In contrast to TE, the manufacturer of the ARFI
device initially did not recommend use of the technical
parameters IQR and SR, but a previous study published
by our group (Bota et al. 2011) indicated that the correla-
tion of LS assessed by ARFI with fibrosis was signifi-
cantly better in patients in whom ARFI measurements
had good technical parameters, compared with those
with high IQR and/or low SR. Currently, the manufac-
turer specifies that the IQR parameter seems to improve
Fig. 3. Supersonic shear imaging measurement. The measure-
ment is performed inside of the circle which is positioned in
an area of homogeneous color. On the screen are displayed
the mean, minimum, maximum and standard deviation of the
measurement, as well as the diameter of the circle.
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a fixed manufacturer-recommended protocol. For these
reasons, in this study, we decided to use the same criteria
for defining failed, unreliable and valid measurements as
used for TE.
To discriminate between the various stages of
fibrosis using ARFI results, we employed the LS cutoffs
proposed in a recently published meta-analysis
(Friedrich-Rust et al. 2012): 1.34 m/s for significant
fibrosis (F $ 2) and 1.8 m/s for liver cirrhosis (F 5 4).
Supersonic shear imaging
Supersonic shear imaging was performed with an
Aixplorer ultrasound system (SuperSonic Imagine, Aix-
en-Provence, France), using a SC6–1 convex probe.
The principle underlying SSI involves the combination
of a radiation force induced in tissues by focused ultra-
sonic beams and a very high frame rate ultrasound
imaging sequence able to capture the propagation of re-
sulting shear waves in real time. The ultrasound system
captures the generated shear waves. To capture them in
sufficient detail, frame rates of a few thousands of images
per second are needed. This ultrafast imaging mode
acquires raw radiofrequency data at a very high frame
rate, up to 5000 frames/s. Shear wave speed is then esti-
mated by a Doppler-like acquisition over a region of
interest. The shear wave speed is used to calculate tissue
stiffness. Elasticity is displayed using a color-coded
image superimposed on a B-mode image: where stiffer
tissues appear red and softer tissues appear blue. At the
same time, LS is quantitatively estimated; the mean LS
value in the region of interest, as well as the standard
deviation of the measured elasticity, is displayed on the
screen, expressed in kilopascals (Bercoff et al. 2004,
Muller et al. 2009) or, if the operator chooses, meters
per second.
For each patient, five valid SSI measurements were
performed under fasting conditions, with the patient in
supine position, with the right arm in maximum abduc-
tion, by the intercostal approach, in the right liver lobe,
2 cm under the liver capsule, in an area of parenchyma
free of large vessels, using a box of 3.53 2.5 cm in which
a 1-cm-diameter circular region of interest was selected
(Fig. 3). Themedian value of five valid SSI measurements
was calculated (expressed in kilopascals) and considered
indicative of the severity of fibrosis.
As for ARFI elastography, the manufacturer of the
SSI device did not recommend any technical parameter
for quality assessment of the measurements. Because it
has been reported that in ARFI elastography, the correla-
tion of LS measurements with fibrosis is significantly
better in cases with measurements with good technical
parameters (Bota et al. 2011), we decided to use IQR
and SR to assess the quality of SSI measurements.Thus, for defining failed, unreliable and reliable LS
measurements, respectively, the same criteria used for
TE and ARFI were used for SSI.
The SSI measurements were performed by the same
operators who performed ARFI measurements. During
one working day, each operator performed either SSI or
ARFI measurements, in different rooms, so that they
were blinded to all clinical and elastographic data.
Also, the operators who performed SSI and ARFI
measurements did not perform TE measurements.
To estimate fibrosis by means of SSI, we used the
cutoffs proposed in the largest published study that
compared SSI measurements with liver biopsy results
(Ferraioli et al. 2012): 7.1 kPa for significant fibrosis
(F $ 2) and 10.4 kPa for liver cirrhosis (F 5 4).
We decided to perform only five SSI measurements
because in the other published studies, such as Ferraioli
et al. (2012) and Bavu et al. (2011), only four or five
SSI measurements were performed, and we used these
studies to evaluate our results. It should also be specified
that SSI measurements are more time consuming than
ARFI or TE measurements.
Statistical analysis
Statistical analysis was performed using MedCalc
Software (MedCalc Software bvba, Ostend, Belgium).
The Kolmogrov-Smirnov test was used for testing the
distribution of numerical variables. Means and standard
deviations were calculated for numerical variables with
a normal distribution, whereas for variables with a non-
normal distribution, medians and ranges were calculated.
Qualitative variables are expressed as numbers and
percentages. A parametric test (t-test) was used to assess
differences between numerical variables with a normal
ARFI and SSI vs. TE for liver fibrosis assessment d I. SPOREA et al. 1937distribution; and a nonparametric test (Mann–Whitney or
Kruskal–Wallis test) was used for variables with a non-
normal distribution. The c2 test (with Yates’ correction
for continuity) was used to compare proportions ex-
pressed as percentages (n 5 total number of patients
included in a particular subgroup). Ninety-five percent
confidence intervals were calculated for each predictive
test. A p-value,0.05 was considered as indicating signif-
icance for each statistic test.RESULTS
The main characteristics of the patients included in
the study are summarized in Table 1.
Reliable LSmeasurements were obtained in a signif-
icantly higher percentage of patients by ARFI elastogra-
phy compared with TE and SSI: 92.1% versus 72.2%
(p , 0.0001) and 92.1% versus 71.3% (p , 0.0001),
respectively. The rates of reliable LS measurements for
TE and SSI were similar: 72.2% and 71.3% (p 5 0.86).
In only 4 patients (1.2%) reliable LS measurements
could not be obtained with any of the three elastographic
methods.
Higher body mass index (BMI) and older age were
significantly associated with inability to obtain reliable
LS measurements for both TE and SSI. In SSI measure-
ments, the presence of chronic hepatopathies was also
associated with failed and unreliable measurements. No
factors were identified as significantly associated with
the inability to obtain reliable LS measurements by
ARFI elastography (Table 2).
In obese patients also (BMI $ 30 kg/m2, 21% of all
patients included in study), reliable LS measurements
were obtained in a significantly higher percentage of
patients by ARFI elastography compared with TE and
SSI: 87.1% versus 30.4 % (p, 0.0001) and 87.1% versus
40% (p , 0.0001), respectively; TE and SSI had similarTable 1. Main characteristics of patientsy
Age, y 53 (18–79)
Gender
Male 144 (43.4%)*
Female 188 (56.6%)
Body mass index (kg/m2) 26.4 6 5.3
Diagnosis (n)
Healthy volunteers 56 (16.9%)
Chronic hepatitis B 63 (18.9%)
Chronic hepatitis C 86 (25.9%)
Chronic non-viral hepatitis 91 (27.4%)
Cirrhosis 36 (10.9%)
Alanine aminotransferase (U/L) 57 (18–650)
Aspartate aminotransferase (U/L) 60 (25–685)
* Variables with a normal distribution are expressed as the mean-
6 standard deviation; variables with a non-normal distribution are
expressed as the median and range.
y Number (%) of patients.rates of reliable measurements in obese patients: 30.4%
and 40% (p 5 0.31).
Reliable LS measurements by all three shear wave
ultrasound elastographic methods were obtained in 184
of 332 patients (55.4%). We used this cohort to study
the performance of ARFI and SSI in the diagnosis of
significant fibrosis (F $ 2) and cirrhosis (F 5 4), with
TE as the reference method, because it is a validated
method for liver fibrosis assessment.
Significant fibrosis was diagnosed in 46% of cases
by TE, with 7.2 kPa as the cutoff LS value. As we
mentioned under Methods, we considered the following
LS values as cutoffs for significant fibrosis (F $ 2):
1.34 m/s for ARFI and 7.1 kPa for SSI elastography.
The sensitivity, specificity and accuracy of ARFI and
SSI in the diagnosis of significant fibrosis were similar
(Table 3).
Liver cirrhosis was diagnosed in 12.5% of cases by
TE, using 14.5 kPa as the cutoff LS value. For ARFI
and SSI elastography, we used the following cutoff
values: 1.8 m/s and 10.4 kPa, respectively. The sensi-
tivity, positive predictive value (PPV) and accuracy of
ARFI and SSI were similar for the diagnosis of cirrhosis,
whereas the specificity and negative predictive value
(NPV) were significantly better for SSI (Table 3).
Supersonic shear imaging was significantly more
accurate in the diagnosis of cirrhosis than in the diagnosis
of significant fibrosis: accuracy 5 85.8 versus 74.4%
(p 5 0.01). ARFI elastography diagnosed cirrhosis and
significant fibrosis with similar accuracy: 78.2% versus
72.2% (p 5 0.22).DISCUSSION
At this time, there is an ongoing debate over the
invasive or non-invasive assessment of liver fibrosis. In
some European countries, such as France, non-invasive
methods for evaluation of liver fibrosis are used exten-
sively, but in other countries, such as the United States
(US), mainly liver biopsy is used in daily practice for
hepatic fibrosis assessment. It should be noted that TE
is not used in the United States because of the lack of
Food and Drug Administration approval.
To our best knowledge, this study is the first to
compare the three most frequently used shear wave
elastographic methods (TE, ARFI and SSI) for LS
assessment.
The main aim of the study was to assess the ‘‘intent-
to-diagnose’’ value of the three elastographic methods,
because before analysis of any method’s accuracy, reli-
able measurements should be obtained. A significantly
higher percentage of reliable LS measurements were
made with ARFI, compared with TE and SSI, whereas
similar rates of reliable measurements were made with
Table 2. Factors associated with the inability to obtain reliable liver stiffness measurements by all three elastographic methods*
Transient elastography (TE)
Parameter
Reliable LS measurements
n 5 240 (72.2%)
Failed or unreliable LS measurements
n 5 92 (27.8%) p
Age (y) 52 (18–78) 57 (21–79) 0.0002
Gender
Male 103 (42.9%)y 41 (44.5%) 0.88
Female 137 (57.1%) 51 (55.5%) 0.88
Body mass index (kg/m2) 25.1 6 4.1 30.1 6 6.2 ,0.0001
Alanine aminotransferase (U/L) 67 (18–650) 53 (25–145) 0.10
Chronic hepatopathies
Yes 194 (80.8%) 82 (89.1%) 0.10
No 46 (19.2%) 10 (10.9%) 0.10
Cirrhosis
Yes 23 (9.6%) 13 (14.1%) 0.32
No 217 (90.4%) 79 (85.9%) 0.32
ARFI elastography
Parameter
Reliable LS measurements
n 5 306 (92.1%)
Failed or unreliable LS measurements
n 5 26 (7.9%) p
Age (y) 54 (18–79) 47 (24–67) 0.15
Gender
Male 134 (43.8%) 10 (38.4%) 0.74
Female 172 (56.2%) 16 (61.6%) 0.74
Body mass index (kg/m2) 26.3 6 5.2 28.2 6 6.5 0.07
Alanine aminotransferase (U/L) 65 (18–650) 54 (28–95) 0.24
Chronic hepatopathies
Yes 258 (84.3%) 19 (73.1%) 0.23
No 48 (15.7%) 7 (26.9%) 0.23
Cirrhosis
Yes 34 (11.1%) 2 (7.7%) 0.83
No 272 (88.9%) 24 (92.3%) 0.83
Supersonic shear imaging (SSI)
Parameter
Reliable LS measurements
n 5 237 (71.3%)
Failed or unreliable LS measurements
n 5 95 (27.8%) p value
Age (y) 52 (18–78) 57 (22–79) ,0.0001
Gender
Male 109 (45.9%) 35 (36.8%) 0.16
Female 128 (54.1%) 60 (63.2%) 0.16
BMI (kg/m2) 24.9 6 4.4 30.3 6 5.5 ,0.0001
Alanine aminotransferase (U/L) 53 (18–650) 70 (22–350) 0.23
Chronic hepatopathies
Yes 191 (80.5%) 86 (90.5%) 0.04
No 46 (19.5%) 9 (9.5%) 0.04
Cirrhosis
Yes 25 (10.5%) 11 (11.6%) 0.92
No 212 (89.5%) 84 (88.4%) 0.92
LS 5 liver stiffness.
In bold are differences statistically significant.
* Numerical variables with a normal distribution are expressed as the mean6 standard deviation, whereas variables with a non-normal distribution
are expressed as the median value and range.
y Number (%) of patients.
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in our study was lower that in Castera et al. (2010) (72.2%
vs. 83%–84%), probably because of the higher BMI of
our patients. Similarly to the study of Castera et al.
(2010), higher BMI and older age were associated with
failed and unreliable measurements. The same factors,
in addition to the presence of chronic hepatopathies,were associated with the inability to obtain reliable LS
measurements using SSI.
The percentage of reliable SSI measurements was
much lower than that in Ferraioli et al. (2012), who eval-
uated 121 patients with chronic hepatitis C (71.3% vs.
97.5%). Possible explanations for this difference are the
higher BMI, older age and heterogeneity of our cohort.
Table 3. Performance of ARFI and SSI in diagnosis of significant fibrosis and cirrhosis, with TE as the reference method for liver
fibrosis assessment
Sensitivity (%) Specificity (%) Positive predictive value (%) Negative predictive value (%) Accuracy (%)
ARFI SSI p ARFI SSI p ARFI SSI p ARFI SSI p ARFI SSI p
Significant fibrosis
(F $ 2)
75.5 79.1 0.48 69.3 70.4 0.90 68.4 70.1 0.81 76.4 79.3 0.58 72.2 74.4 0.71
Liver cirrhosis (F 5 4) 86.9 82.6 0.31 77 86.3 0.03 35.1 46.3 0.03 97.6 97.2 0.93 78.2 85.8 0.07
ARFI 5 acoustic radiation force impulse; SSI 5 supersonic shear imaging.
ARFI and SSI vs. TE for liver fibrosis assessment d I. SPOREA et al. 1939It should also be mentioned that Ferraioli et al. (2012) did
not use the quality technical parameters IQR and SR for
SSI measurements, but even if we had not used these
quality parameters, the rate of valid LS measurements
would still have been much lower in our study: 77.1%
versus 97.5%. When only obese patients were analyzed,
the percentage of reliable LS measurements was approx-
imately 40% for TE and SSI and more than double that
for ARFI. The obesity problem was partially solved for
TE by the recent development of a more sensitive ultra-
sound sensor (XL probe), which also has the ability to
non-invasively quantify liver steatosis (de Ledinghen
et al. 2010; Myers et al. 2012), but greatly increases the
device’s cost.
As opposed to the other two elastographic methods,
in ARFI elastography, even though BMI was higher in
patients with failed and unreliable LS measurements
compared with those with reliable measurements, the
difference did not reach statistical significance, probably
because of the relatively small number of cases in which
reliable LSmeasurements could not be obtained. Also, no
other factors were identified as significantly associated
with failed and unreliable ARFI measurements.
Our secondary aim was to compare the performance
of ARFI elastography and SSI in liver fibrosis assess-
ment, with TE as the reference method. We chose TE
as the reference method because it is the only
ultrasound-based elastographic method recognized for
non-invasive liver fibrosis assessment, being included in
the guidelines of the European Association for the Study
of the Liver (EASL) as a tool for liver fibrosis assessment
in patients with chronic hepatopathies, especially chronic
hepatitis C (European Association for the Study of the
Liver 2011, 2012). According to the meta-analysis of
Tsochatzis et al. (2011), which included 40 studies, TE
performed well in predicting liver cirrhosis, considering
liver biopsy as the ‘‘gold standard,’’ with a summary
sensitivity of 0.83 (95% confidence interval [CI]:
0.79–0.86) and a summary specificity of 0.89 (95% CI:
0.87–0.91). TE performed less well in predicting signifi-
cant fibrosis, but the performance was still good, with
a summary sensitivity of 0.79 (95% CI: 0.74–0.82) and
a summary specificity of 0.78 (95% CI: 0.72–0.83). Inour study, liver biopsy, still considered the ‘‘gold stan-
dard’’ for liver fibrosis assessment, was not available.
But it should be specified that liver biopsy is not perfect.
To be accurately interpreted by the pathologist, the liver
biopsy specimen should be at least 1.5 cm long
(Friedman 2004), ideally 4 cm (Bedossa et al. 2003),
and include at least 8 (Grant and Neuberger 1999) or 11
(Guido and Rugge 2004) portal tracts, in the opinion of
other authors. Published studies indicate that up to 20%
of liver biopsy specimens are not large enough to be inter-
preted by the pathologist (Beaugrand 2006). Also, the
inter- and intra-observer diagnostic discrepancies in
biopsy assessment of liver fibrosis are important
(Bedossa et al. 1994; Rousselet et al. 2005), whereas
TE measurements have very good intra- and inter-
observer agreement (Fraquelli et al. 2007). Last, but not
least, liver biopsy is an invasive method and is not accept-
able to all patients, especially if repeated evaluations are
needed.
Even if SSI and TE values are reported as Young’s
modulus values, the cutoff values are not equal if different
elastographic methods are used. If all cutoff values were
to be reported in meters per second, the cutoff values for
predicting significant fibrosis and liver cirrhosis would
be 1.34 and 1.80 m/s for ARFI elastography, 1.55 and
2.20 m/s for TE and for 1.54 and 1.86 m/s for SSI. An
explanation for the divergent values is the different tech-
nical principles underlying these techniques.
Several published studies have compared different
elastographic methods for assessment of liver fibrosis.
Most of the published studies that compared the value
of TE and ARFI elastography in liver fibrosis evalua-
tion, with liver biopsy as the reference method, reported
similar performance in predicting significant fibrosis
and cirrhosis (Colombo et al. 2012; Ebinuma et al.
2011; Friedrich-Rust et al. 2009a, 2009b; Kircheis
et al. 2012; Sporea et al. 2010), but some studies did
indicate that TE (Lupsor et al. 2009) or ARFI elastogra-
phy (Rizzo et al. 2011) was significantly better. In the
meta-analysis by Friedrich-Rust et al. (2012), which
included 312 patients from four studies in which LS
was evaluated using ARFI and TE, the statistical anal-
ysis revealed that TE performed significantly better.
1940 Ultrasound in Medicine and Biology Volume 39, Number 11, 2013Recently, in another meta-analysis (presented so far
only as an abstract), including 840 patients from eight
studies who were evaluated with ARFI, TE and liver
biopsy (Bota et al. 2012), the odds ratios for ARFI
and TE for the detection of significant fibrosis and
cirrhosis were similar.
Until now, only two published studies (Bavu et al.
2011; Ferraioli et al. 2012) have compared TE with SSI
in evaluation of liver fibrosis. Both reported that SSI
performed significantly better in diagnosing significant
fibrosis, whereas TE and SSI performed similarly in
predicting liver cirrhosis. Our study is the first to
compare SSI with ARFI elastography, with TE as the
reference method, for liver fibrosis assessment. To
decrease the risk of bias, we decided to use, for TE and
ARFI, the cutoff values proposed by the latest published
meta-analysis (Friedrich-Rust et al. 2012; Tsochatzis
et al. 2011) and, for SSI, the cutoff values published by
the largest study to compare SSI with liver biopsy
(Ferraioli et al. 2012). The accuracy rates of ARFI and
SSI were similar for the diagnosis of significant fibrosis
and cirrhosis. Similar to published data (Fierbinteanu-
Braticevici et al. 2009; Friedrich-Rust et al. 2009a,
2009b; Sporea et al. 2011), in our study SSI had better
accuracy in the diagnosis of liver cirrhosis than in the
diagnosis of significant fibrosis, whereas for ARFI elas-
tography, the accuracy rates were similar.
In daily practice, seldom more than one non-
invasive elastographic method for liver fibrosis assess-
ment is available at any center. Thus, the hepatologist
must choose the most cost-effective one. According to
our results, ARFI elastography could be this method, as
it has a significantly higher rate of reliable LS measure-
ments, compared with TE or SSI, and is similar in accu-
racy to SSI in diagnosing significant fibrosis and liver
cirrhosis. Also, as previously noted, most of the published
studies (Bota et al. 2012; Colombo et al. 2012; Ebinuma
et al. 2011; Friedrich-Rust et al. 2009a, 2009b; Kircheis
et al. 2012; Sporea et al. 2010) have reported similar
accuracy for ARFI and TE in the evaluation of liver
fibrosis. ARFI has another advantage compared with
TE: It can be integrated into a standard ultrasound
system (which can also be used for standard ultrasound
evaluation, contrast-enhanced ultrasound and/or Doppler
examinations).CONCLUSIONS
Acoustic radiation force impulse elastography is the
most feasible shear wave elastographic method for
assessment of liver fibrosis, especially in obese patients,
whereas TE and SSI are similar with respect to rate of
reliable LS measurements. With TE as the reference
method for liver fibrosis evaluation, ARFI and SSI hadsimilar rates accuracy in diagnosing significant fibrosis
and liver cirrhosis.REFERENCES
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